Send to

Choose Destination
Cathet Cardiovasc Diagn. 1998 Nov;45(3):264-8.

Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.

Author information

Department of Pediatrics, University of Utah and Primary Children's Medical Center, Salt Lake City 84113, USA. pcs


A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin. She did not develop evidence of ischemia, had no complications from the therapy, and showed resolution of the aneurysms and thrombi after 6 wk of therapy.

Supplemental Content

Loading ...
Support Center